| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...5.8773O |
| P356 | DOI | 10.1371/JOURNAL.PONE.0008773 |
| P932 | PMC publication ID | 2808252 |
| P698 | PubMed publication ID | 20098743 |
| P5875 | ResearchGate publication ID | 41124124 |
| P50 | author | Ryusuke Kuwahara | Q57624141 |
| Ryota Hashimoto | Q63043161 | ||
| Hiroaki Okuda | Q40017133 | ||
| P2093 | author name string | Taiichi Katayama | |
| Masaya Tohyama | |||
| Shoko Shimizu | |||
| Keisuke Kawamoto | |||
| Kohei Yamada | |||
| Masatoshi Takeda | |||
| Natsuko Kumamoto | |||
| Shingo Miyata | |||
| Shinsuke Matsuzaki | |||
| Tsuyoshi Hattori | |||
| P2860 | cites work | Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings | Q21203814 |
| Association of neuregulin 1 with schizophrenia confirmed in a Scottish population | Q24561773 | ||
| Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia | Q24612644 | ||
| Neuregulin 1 and susceptibility to schizophrenia | Q24616921 | ||
| Disruption of two novel genes by a translocation co-segregating with schizophrenia | Q28144559 | ||
| Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth | Q28188775 | ||
| Confirming RGS4 as a susceptibility gene for schizophrenia | Q28241823 | ||
| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 | ||
| Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain | Q28505394 | ||
| Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization | Q28508993 | ||
| Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia | Q28568230 | ||
| The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. | Q28568657 | ||
| Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
| NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders | Q29617936 | ||
| A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. | Q30830598 | ||
| Synaptic plasticity and dysconnection in schizophrenia | Q31030180 | ||
| Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness | Q33782621 | ||
| Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo | Q33889834 | ||
| The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease | Q33905352 | ||
| Association of the DTNBP1 locus with schizophrenia in a U.S. population | Q33910454 | ||
| Two pathways control chromaffin cell cortical F-actin dynamics during exocytosis | Q33949121 | ||
| Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). | Q33977237 | ||
| Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria | Q33977974 | ||
| Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 | ||
| Role of the CCAAT-binding protein CBF/NF-Y in transcription | Q34470368 | ||
| Variation in the dysbindin gene and normal cognitive function in three independent population samples. | Q51944823 | ||
| Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. | Q52009093 | ||
| Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. | Q53621277 | ||
| A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis | Q57699655 | ||
| Evidence for a susceptibility locus for schizophrenia on chromosome 6pter–p22 | Q71990853 | ||
| Family-based association study of DTNBP1 in 6p22.3 and schizophrenia | Q73729298 | ||
| Neurobiology of schizophrenia | Q79173267 | ||
| RNF151, a testis-specific RING finger protein, interacts with dysbindin | Q80496881 | ||
| Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia | Q81299308 | ||
| Genetic variation in DTNBP1 influences general cognitive ability | Q34484915 | ||
| Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. | Q34526304 | ||
| Pathophysiologically based treatment interventions in schizophrenia | Q34570681 | ||
| Synaptotagmin I, a Ca2+ sensor for neurotransmitter release | Q35192506 | ||
| New Aspects of Neurotransmitter Release and Exocytosis: Rho-Kinase-Dependent Myristoylated Alanine-Rich C-Kinase Substrate Phosphorylation and Regulation of Neurofilament Structure in Neuronal Cells | Q35538979 | ||
| Bringing order to the glutamate chaos in schizophrenia | Q35601575 | ||
| Evolution of antipsychotic intervention in the schizophrenic psychosis | Q36611887 | ||
| Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment | Q36899309 | ||
| A highly significant association between a COMT haplotype and schizophrenia. | Q37203703 | ||
| Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia | Q37698891 | ||
| Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients | Q38309861 | ||
| Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. | Q39791058 | ||
| Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters | Q40270857 | ||
| Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families | Q40722387 | ||
| Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. | Q40810638 | ||
| Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells. | Q42500692 | ||
| Association and linkage analyses of RGS4 polymorphisms in schizophrenia | Q42676740 | ||
| Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. | Q44174109 | ||
| Support for RGS4 as a susceptibility gene for schizophrenia | Q44734498 | ||
| Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families | Q44894348 | ||
| Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families | Q44903817 | ||
| A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. | Q45081613 | ||
| Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. | Q46538656 | ||
| Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. | Q46610682 | ||
| Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. | Q46931688 | ||
| Dopamine receptor excess and mouse madness | Q46942967 | ||
| Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain | Q47378030 | ||
| High dopamine turnover in the brains of Sandy mice. | Q48147327 | ||
| Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. | Q48246615 | ||
| Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). | Q50305183 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e8773 | |
| P577 | publication date | 2010-01-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain | |
| P478 | volume | 5 |
| Q37723680 | Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia |
| Q30428226 | Behavioral characterization of mice overexpressing human dysbindin-1. |
| Q35875021 | Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene. |
| Q88667593 | Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia |
| Q30474256 | Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade. |
| Q38321358 | Molecular basis of major psychiatric diseases such as schizophrenia and depression |
| Q37952284 | NF-Y and the transcriptional activation of CCAAT promoters. |
| Q24301877 | Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression |
| Q33803921 | Reduced rate of neural differentiation in the dentate gyrus of adult dysbindin null (sandy) mouse |
| Q24625434 | Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila |
| Q35690513 | The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus |
Search more.